Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
0.9837
-0.0463 (-4.50%)
At close: Sep 15, 2026, 4:00 PM EDT
1.020
+0.036 (3.69%)
After-hours: Sep 15, 2026, 7:43 PM EDT
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $23.62 million as of September 15, 2026. Its market cap has decreased by -84.55% in one year.
Market Cap
23.62M
Enterprise Value
19.20M
1-Year Change
-84.55%
Ranking
Category
Stock Price
$0.98
ChartMarket Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has decreased from $152.13M to $23.62M, a decrease of -84.47%. That is a compound annual growth rate of -58.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 23.62M | -83.39% |
| Dec 31, 2025 | 142.25M | -8.50% |
| Dec 31, 2024 | 155.47M | 2.20% |
| Aug 13, 2024 | 152.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CEL-SCI | 26.21M |
| Evaxion | 26.10M |
| Quantum BioPharma | 25.88M |
| ABVC BioPharma | 25.41M |
| Atossa Therapeutics | 25.05M |
| Tvardi Therapeutics | 24.94M |
| Radiopharm Theranostics | 24.89M |
| Cocrystal Pharma | 23.89M |